Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EpiPen Generics: Woodcock Explains Injector Studies

Sep 22 2016

• By Derrick Gingery

EpiPen

Related Content

EpiPen Familiarity May Prove Tough Hurdle For Generics

Sep 12 2016

Mylan’s EpiPen Defense Against Generics Focuses On Device Design

Jan 22 2015

Mylan’s EpiPen Exclusivity Saved Again As Teva Reports CRL

Mar 01 2016

Drug Pricing Panacea Or Just PR Victory? Expedited ANDAs May Have Limited Impact

Mar 21 2016

Scrutiny Of EpiPen Pricing Invited By Mylan Lobbying, Congressman Says

Sep 22 2016

Mylan's EpiPen Nightmare Not Over Yet, But Will Congress Just Write?

Aug 30 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Sanofi

Viatris Inc.

Additional Topics

United States Drug Approval Standards Intellectual Property Regulation Combination Products BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window